These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17623573)

  • 41. Outcome of second trimester amniocentesis in twin pregnancies at Songklanagarind Hospital.
    Hanprasertpong T; Kor-anantakul O; Prasartwanakit V; Leetanaporn R; Suntharasaj T; Suwanrath C
    J Med Assoc Thai; 2008 Nov; 91(11):1639-43. PubMed ID: 19127782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RETIRED: Prenatal screening for fetal aneuploidy.
    Summers AM; Langlois S; Wyatt P; Douglas Wilson R; ; ;
    J Obstet Gynaecol Can; 2007 Feb; 29(2):146-161. PubMed ID: 17346485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Amniocentesis practice assessment of the south-west Francilian network during 2003].
    Laperrelle J; Senat MV; Picone O; Fernandez H; Frydman R
    J Gynecol Obstet Biol Reprod (Paris); 2008 Apr; 37(2):135-42. PubMed ID: 18036746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RETIRED: Prenatal screening, diagnosis, and pregnancy management of fetal neural tube defects.
    Wilson RD; ;
    J Obstet Gynaecol Can; 2014 Oct; 36(10):927-939. PubMed ID: 25375307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of spontaneous fetal loss rates between women with singleton and twin pregnancies after mid-trimester amniocentesis - A historical cohort study.
    Chen J; Liu L; Xia D; He F; Wang Q; Li T; Lai Y; Liu S; Zhang Z
    Prenat Diagn; 2020 Sep; 40(10):1315-1320. PubMed ID: 32584427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amniocentesis-related adverse outcomes according to placental location and risk factors for fetal loss after midtrimester amniocentesis.
    Kalogiannidis I; Prapa S; Dagklis T; Karkanaki A; Petousis S; Prapas Y; Prapas N
    Clin Exp Obstet Gynecol; 2011; 38(3):239-42. PubMed ID: 21995155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fetal loss rate after chorionic villus sampling and subsequent amniocentesis.
    Brandenburg H; Jahoda MG; Pijpers L; Reuss A; Kleyer WJ; Wladimiroff JW
    Am J Med Genet; 1990 Feb; 35(2):178-80. PubMed ID: 2309754
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amniocentesis and chorionic villus sampling in twin gestations: which is the best sampling technique?
    Simonazzi G; Curti A; Farina A; Pilu G; Bovicelli L; Rizzo N
    Am J Obstet Gynecol; 2010 Apr; 202(4):365.e1-5. PubMed ID: 20060095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RETIRED: Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy.
    Magee LA; Helewa M; Rey E; ;
    J Obstet Gynaecol Can; 2008 Mar; 30(3 Suppl):S1-S2. PubMed ID: 18817592
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The risk of second-trimester amniocentesis in twin gestations: a case-control study.
    Ghidini A; Lynch L; Hicks C; Alvarez M; Lockwood CJ
    Am J Obstet Gynecol; 1993 Oct; 169(4):1013-6. PubMed ID: 8238111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic amniocentesis: impact of placental position upon the risk of pregnancy loss.
    Crane JP; Kopta MM
    Am J Obstet Gynecol; 1984 Dec; 150(7):813-6. PubMed ID: 6391172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum alpha-fetoprotein screening and risk of amniocentesis.
    Brock DJ; Gosden C
    Lancet; 1979 Jul; 2(8135):206. PubMed ID: 89325
    [No Abstract]   [Full Text] [Related]  

  • 53. Advanced maternal age as a sole indication for genetic amniocentesis; risk-benefit analysis based on a large database reflecting the current common practice.
    Bornstein E; Lenchner E; Donnenfeld A; Barnhard Y; Seubert D; Divon MY
    J Perinat Med; 2009; 37(2):99-102. PubMed ID: 18999912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fetal loss associated with second trimester amniocentesis.
    Pitukkijronnakorn S; Promsonthi P; Panburana P; Udomsubpayakul U; Chittacharoen A
    Arch Gynecol Obstet; 2011 Oct; 284(4):793-7. PubMed ID: 21052703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pregnancy outcome following second-trimester amniocentesis: a case-control study.
    Müngen E; Tütüncü L; Muhcu M; Yergök YZ
    Am J Perinatol; 2006 Jan; 23(1):25-30. PubMed ID: 16450269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RETIRED: Investigation and management of non-immune fetal hydrops.
    Désilets V; Audibert F;
    J Obstet Gynaecol Can; 2013 Oct; 35(10):923-38. PubMed ID: 24165062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hemorrhagic shock caused by intraperitoneal hemorrhage after amniocentesis].
    Jung V; Künzig HJ
    Geburtshilfe Frauenheilkd; 1995 Jul; 55(7):411-3. PubMed ID: 7557210
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcome of second trimester amniocentesis in singleton pregnancy at Songklanagarind Hospital.
    Hanprasertpong T; Kor-anantakul O; Prasartwanakit V; Leetanaporn R; Suntharasaj T; Suwanrath C
    J Med Assoc Thai; 2011 Nov; 94(11):1288-92. PubMed ID: 22256466
    [TBL] [Abstract][Full Text] [Related]  

  • 59. RETIRED: Cell-free fetal DNA in the maternal circulation and its future uses in obstetrics.
    Wilson RD;
    J Obstet Gynaecol Can; 2005 Jan; 27(1):54-62. PubMed ID: 15937584
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RETIRED: Antenatal corticosteroid therapy for fetal maturation.
    Crane J; Armson A; Brunner M; De La Ronde S; Farine D; Keenan-Lindsay L; Leduc L; Schneider C; Van Aerde J;
    J Obstet Gynaecol Can; 2003 Jan; 25(1):45-52. PubMed ID: 12548324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.